{"blog": [], "keywords": [{"value": "Cancer", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Preventive Medicine", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Health Affairs (Journal)", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Research", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Prostate Cancer", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Breast Cancer", "name": "subject", "rank": "6", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/14/upshot/why-survival-rate-is-not-the-best-way-to-judge-cancer-spending.html", "document_type": "article", "byline": {"person": [{"middlename": "E.", "firstname": "Aaron", "role": "reported", "rank": 1, "lastname": "CARROLL", "organization": ""}], "original": "By AARON E. CARROLL"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/04/14/books/review/14up-Health/14up-Health-thumbWide.jpg", "legacy": {"wide": "images/2015/04/14/books/review/14up-Health/14up-Health-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/04/14/books/review/14up-Health/14up-Health-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/14/books/review/14up-Health/14up-Health-articleLarge.jpg", "xlargeheight": "413", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 413}, {"url": "images/2015/04/14/books/review/14up-Health/14up-Health-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/14/books/review/14up-Health/14up-Health-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "The Upshot", "word_count": "1222", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "For many cancers in the United States, we\u2019ve made little headway in mortality rates, which is a different measure altogether.", "pub_date": "2015-04-14T00:00:00Z", "news_desk": "Upshot", "headline": {"kicker": "The Upshot", "main": "Why Survival Rate Is Not the Best Way to Judge Cancer Spending  ", "content_kicker": "The New Health Care"}, "print_page": null, "snippet": "For many cancers in the United States, we\u2019ve made little headway in mortality rates, which is a different measure altogether.", "_id": "552ba1b938f0d824bd2ece77", "slideshow_credits": null, "abstract": null}